Loading chat...
TN HB2246
Bill
Status
2/2/2026
Primary Sponsor
Chris Hurt
Click for details
AI Summary
-
Physicians may perform stem cell therapies not approved by the FDA for orthopedics, wound care, or pain management, provided stem cells are obtained from FDA-registered facilities with certification from organizations like the National Marrow Donor Program or American Association of Tissue Banks
-
Advertisements for stem cell therapy must include a required notice stating the treatment is not FDA-approved, and physicians must obtain signed informed consent forms disclosing the experimental nature, risks, and alternatives
-
Stem cell therapy explicitly excludes the use of cells or tissues derived from a fetus or embryo after an abortion; intentionally performing such treatment or research constitutes a Class E felony
-
Sale, manufacture, or distribution of computer products created using human cells, tissues, or cellular tissue-based products is also classified as a Class E felony
-
Takes effect July 1, 2026, with rulemaking authority granted to the Board of Medical Examiners and Board of Osteopathic Examination effective immediately upon passage
Legislative Description
AN ACT to amend Tennessee Code Annotated, Title 63 and Title 68, relative to stem cell therapies.
Health Care
Last Action
Placed on s/c cal Health Subcommittee for 3/18/2026
3/11/2026